A study conducted by U.S. Department of Agriculture (USDA) scientists provides additional confirmation that meat and tissue from pigs exposed to two strains of the 2009 novel pandemic H1N1 virus did not contain virus.

15 January 2010 -- As of 10 January 2010, worldwide more than 208 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including at least 13554 deaths.

In July 2009, the Advisory Committee on Immunization Practices (ACIP) issued recommendations for use of the influenza A (H1N1) 2009 monovalent vaccine (1). Recognizing that the vaccine supply would not be ample immediately but would grow over time, ACIP identified 1) initial target groups, consisting of approximately 160 million persons, and 2) a limited vaccine subset of the target groups, initially estimated at 42 million persons (and more recently estimated at 62 million persons), to receive first priority while the 2009 H1N1 vaccine supply was limited (1). ACIP recommended expanding vaccination to the rest of the population as vaccine supplies increased. To estimate 2009 H1N1 vaccination coverage to date for the 2009--10 influenza season, CDC analyzed results from the National 2009 H1N1 Flu Survey (NHFS) and the Behavioral Risk Factor Surveillance System (BRFSS) survey, conducted during December 27, 2009--January 2, 2010, and December 1--27, 2009, respectively.

National Influenza Vaccination Week continues with a focus on the importance of young adults getting vaccinated against the H1N1 flu. Today, U.S. Department of Health and Human Services Secretary Kathleen Sebelius will visit Hunter College in New York City for a roundtable discussion with students and faculty about the H1N1 flu. Secretary Sebelius will also announce a new Facebook application called, "I'm a Flu Fighter" that allows users to tell their friends that they received the flu vaccination and urge others to do the same.

The purpose of this document is to provide information to state and local immunization programs regarding options for reporting certain criminal, fraud and abuse matters relating to the 2009 H1N1 influenza vaccine and ancillary supplies.

Every American has a role to play in fighting the H1N1 flu.

Many travelers are expected to visit Asia in the upcoming weeks to celebrate the beginning of the Year of the Tiger.

During week 52 (December 27, 2009-January 2, 2010), influenza activity decreased slightly in the U.S.

The U.S. Department of Health and Human Services (HHS) and its Centers for Disease Control and Prevention (CDC) announced a nationwide effort to encourage more Americans to get the H1N1 flu vaccine during National Influenza Vaccination Week, January 1016, 2010.

8 January 2010 -- As of 3 January 2009, worldwide more than 208 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including at least 12799 deaths.

National Influenza Vaccination Week (NIVW) is a national observance that was established to highlight the importance of continuing influenza vaccination, as well as fostering greater use of flu vaccine after the holiday season into January and beyond.

If you have diabetes, you are more likely to get flu-related complications like pneumonia and even be hospitalized or die from the flu than other people. Influenza may also interfere with blood glucose management.

The Centers for Disease Control and Prevention (CDC) is aware that pregnant women, parents of young children, and others may have questions about the safety of thimerosal in vaccines against 2009 H1N1 flu. Here is some information to help you in making decisions.

CDC Updates Influenza-Associated Hospitalizations and Deaths for the week ending December 26, 2009

WHO Updates International H1N1 Flu Situation

As of 20 December 2009, worldwide more than 208 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including at least 11516 deaths.

The U.S. Food and Drug Administration today approved Fluzone High-Dose, an inactivated influenza virus vaccine for people ages 65 years and older to prevent disease caused by influenza virus subtypes A and B.

First, it is important to point out that the recall is not safety-related. As part of its quality assurance program, the manufacturer of the nasal spray monovalent 2009 H1N1 flu vaccine, MedImmune, performs routine, ongoing stability testing of the vaccine.

The National 2009 H1N1 Flu Survey (NHFS) is a nationally representative telephone survey that utilizes both land-line and cell phones. It is designed to get completed interviews with 6,000 households per month and to provide vaccine coverage estimates for adults and children.

Efforts to assess the severity of the H1N1 influenza pandemic sometimes compare numbers of confirmed deaths with those estimated for seasonal influenza, either nationally or worldwide.